Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

4.98
Delayed Data
As of 3:57pm ET
 -0.05 / -0.99%
Today’s Change
3.92
Today|||52-Week Range
8.38
+7.10%
Year-to-Date

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Keryx Biopharmaceuticals Inc have a median target of 7.00, with a high estimate of 9.00 and a low estimate of 5.00. The median estimate represents a +40.56% increase from the last price of 4.98.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Buy stock in Keryx Biopharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.17
Sales
$24.7M
Reporting Date
Jul 31

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 5.82%
 
 
 
 
 
 
Growthannually 58.45%
 
 
 
 
 
 

Sales

Growthquarterly 13.47%
 
 
 
 
 
 
Growthannually 78.19%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.